Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer. The results appeared in a recent issue of...
Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer. The ERCC1 Analysis measures ERCC1 levels in cells to...
Moffitt Cancer Center will host its fourth-annual Business of Biotech: Vision + Drive = Innovation conference from 8 a.m. to 1 p.m. Feb. 1 in the Vincent A. Stabile Research Building, 12902 Magnolia Drive. "We are delighted Dr. Garry Nolan, tenured professor at the Stanford University School...